Enter the first few characters of Company and click 'Go'
Half Yearly Results of Jagsonpal Pharmaceuticals Ltd.(Figures in Rs crores)
|
|
Sep 30, 2023 |
Mar 31, 2023 |
Sep 30, 2022 |
Mar 31, 2022 |
Sep 30, 2021 |
Net Sales / Income |
117.98 |
115.59 |
121.12 |
106.61 |
119.49 |
Other Income |
4.27 |
4.30 |
1.43 |
2.23 |
1.11 |
Net Profit/Loss |
14.95 |
13.39 |
13.33 |
5.43 |
14.16 |
Raw Material |
12.43 |
12.44 |
18.77 |
17.46 |
22.96 |
Power And Fuel |
0 |
0 |
0 |
0 |
0 |
Employee Expenses |
25.41 |
27.40 |
29.87 |
29.21 |
28.47 |
Excise |
|
|
|
|
|
Admin And Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Research And Devlopment Expenses |
0 |
0 |
0 |
0 |
0 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Other Expenses |
60.77 |
62.04 |
47.74 |
51.19 |
45.40 |
Provisions Made |
0 |
0 |
0 |
0 |
0 |
Interest |
0.37 |
0.37 |
0.04 |
0.12 |
0.17 |
Gross Profit |
20.90 |
18 |
21.48 |
8.35 |
20.49 |
Depreciation |
0.85 |
0.81 |
0.40 |
1.02 |
0.51 |
Taxation |
5.10 |
3.80 |
4.29 |
1.91 |
5.83 |
Extra Ordinary Item |
0 |
0 |
-3.46 |
0 |
0 |
Prior Year Adjustments |
0 |
0 |
0 |
0 |
0 |
Equity Capital |
13.10 |
13.10 |
13.10 |
13.10 |
13.10 |
Equity Dividend Rate |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non-Prom. Shares (in lacs) |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non PromotoHolding (%) |
0 |
0 |
0 |
0 |
0 |
EPS (in Rs.) |
5.71 |
5.11 |
5.09 |
2.07 |
5.40 |
|
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article